Segall Bryant & Hamill LLC Invests $5.72 Million in Axcelis Technologies, Inc. $ACLS

Segall Bryant & Hamill LLC acquired a new position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 58,611 shares of the semiconductor company’s stock, valued at approximately $5,723,000. Segall Bryant & Hamill LLC owned about 0.19% of Axcelis Technologies as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Salomon & Ludwin LLC purchased a new stake in Axcelis Technologies during the third quarter valued at about $25,000. Close Asset Management Ltd bought a new position in shares of Axcelis Technologies during the 3rd quarter valued at about $27,000. EverSource Wealth Advisors LLC increased its position in shares of Axcelis Technologies by 145.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 451 shares of the semiconductor company’s stock valued at $31,000 after purchasing an additional 267 shares during the last quarter. Caitlin John LLC purchased a new position in shares of Axcelis Technologies during the 3rd quarter valued at about $32,000. Finally, Strs Ohio bought a new stake in Axcelis Technologies in the 3rd quarter worth approximately $49,000. 89.98% of the stock is currently owned by hedge funds and other institutional investors.

Axcelis Technologies Stock Up 0.9%

ACLS stock opened at $86.62 on Thursday. Axcelis Technologies, Inc. has a fifty-two week low of $40.40 and a fifty-two week high of $102.93. The company has a market capitalization of $2.66 billion, a price-to-earnings ratio of 22.85, a price-to-earnings-growth ratio of 10.27 and a beta of 1.78. The business’s 50 day moving average price is $87.98 and its two-hundred day moving average price is $85.88. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.11 and a current ratio of 4.77.

Axcelis Technologies (NASDAQ:ACLS) last released its earnings results on Tuesday, February 17th. The semiconductor company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.12 by $0.37. The company had revenue of $238.33 million during the quarter, compared to analysts’ expectations of $215.04 million. Axcelis Technologies had a return on equity of 13.73% and a net margin of 14.33%.The firm’s revenue for the quarter was down 5.6% compared to the same quarter last year. During the same quarter last year, the business posted $1.54 EPS. Axcelis Technologies has set its Q1 2026 guidance at 0.710-0.710 EPS. As a group, analysts forecast that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current fiscal year.

Insider Buying and Selling at Axcelis Technologies

In other news, Director Jorge Titinger sold 2,000 shares of the business’s stock in a transaction on Wednesday, December 17th. The shares were sold at an average price of $86.05, for a total transaction of $172,100.00. Following the sale, the director owned 7,477 shares in the company, valued at approximately $643,395.85. The trade was a 21.10% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Gerald M. Blumenstock sold 3,034 shares of the company’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $89.46, for a total transaction of $271,421.64. Following the completion of the sale, the executive vice president directly owned 18,661 shares in the company, valued at $1,669,413.06. This represents a 13.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 6,034 shares of company stock valued at $523,522 in the last three months. Insiders own 0.48% of the company’s stock.

Analysts Set New Price Targets

ACLS has been the topic of a number of recent research reports. Zacks Research cut shares of Axcelis Technologies from a “hold” rating to a “strong sell” rating in a research report on Friday, February 20th. B. Riley Financial reduced their target price on shares of Axcelis Technologies from $94.00 to $91.00 and set a “neutral” rating on the stock in a report on Wednesday, February 18th. Wall Street Zen cut shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, January 3rd. Weiss Ratings restated a “hold (c-)” rating on shares of Axcelis Technologies in a research report on Monday, December 22nd. Finally, Bank of America raised their price objective on Axcelis Technologies from $90.00 to $100.00 and gave the company an “underperform” rating in a research note on Tuesday, January 13th. Two investment analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Axcelis Technologies currently has an average rating of “Hold” and a consensus price target of $101.50.

Axcelis Technologies Profile

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.